View all studies | E-Cigarettes

E-cigarette Research Study

The use of electronic nicotine delivery systems (ENDS) has grown in the last decade.

Accellacare is enrolling a research study for current e-cigarettes, vape, Juul, e-pen users to evaluate an ENDS.

Eligible participants will receive financial compensation for time and travel and access to ENDS for the duration of the study. 

Since the products in this study are not treating any symptoms or illness, there will be no medical benefit. Your participation will provide information about the study products. This might benefit others in the future.


Know someone who may want to participate? Our Tell a Friend program is a great way to share research opportunities. 

Refer someone today.

Submit to learn more:


When you register your interest with Accellacare, our clinical research specialists will review your information at no cost and connect you with studies you may be eligible for. When we find a match, Accellacare may contact you for further pre-screening or we may share your information with a local site office for them to contact you directly. Your data will be processed as outlined in the Accellacare privacy policy


Data Protection

As the data controller for the Improvingtreatments.co.uk, Accellacare is committed to protecting the information that you provide. Where you give us your consent, we may use your information to: (a) identify appropriate clinical trials for you and to let you know about them; and/or (b) send you invitations to participate in future study opportunities. You can withdraw your consent at any time, but we may continue some limited processing where we have other legal grounds for doing so.

Please enter the security code:

Please note: You may or may not benefit medically from taking part and you are able to opt out at anytime and do not have to give us a reason for doing so. Your primary care physician will be informed about your participation and all medical assessments that will be carried out as part of the study. If during screening any abnormal results are found your primary care physician will also be informed.